海欣股份：子公司药品维生素B6注射液通过仿制药一致性评价

Core Viewpoint - Ganhai Xin's vitamin B6 injection has passed the consistency evaluation of quality and efficacy for generic drugs, enhancing its market competitiveness, although it will not significantly impact the company's current operating performance [1] Company Summary - Ganhai Xin, a subsidiary of Haixin Co., has developed a vitamin B6 injection primarily used for preventing and treating vitamin B6 deficiency and as a nutritional supplement for specific populations [1] - The product adheres to the drug registration standards set by the National Medical Products Administration [1] Industry Summary - The estimated sales revenue for public medical institutions in China for vitamin B6 injections is approximately 304 million yuan in 2024 [1]